Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD +0.33%93 OCF Margin % is 10.70% as of Mar. 2026, which is 52% below its 10-year median of 22.12. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.94 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 78.82% on this metric.
The historical rank and industry rank for Viemed Healthcare's OCF Margin % or its related term are showing as below:
VMD'
s OCF Margin % Range Over the Past 10 Years
Min: 17.43 Med: 22.12 Max: 34.7
Current: 19.94
During the past 10 years, the highest OCF Margin % of Viemed Healthcare was 34.70%. The lowest was 17.43%. And the median was 22.12%.
VMD's OCF Margin % is ranked better than 78.82% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs VMD: 19.94
Viemed Healthcare OCF Margin % Related Terms
Viemed Healthcare OCF Margin % Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viemed Healthcare's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a OCF Margin % of 10.70% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Viemed Healthcare and its competitors. This is 52% below median its historical median of 22.12. Over the past decade, Viemed Healthcare's OCF Margin % has ranged from 17.43 to 34.70. According to the industry distribution chart, Viemed Healthcare ranks #173 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 21.2%.
Is Viemed Healthcare's OCF Margin % too high?
Viemed Healthcare's current OCF Margin % of 10.70% is 52% below median its 10-year median of 22.12. Over the past 10 years, this metric has ranged from a low of 17.43 to a high of 34.70. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Viemed Healthcare's value of 10.70% is 83.8% above this industry median. Based on the distribution chart, Viemed Healthcare ranks #173 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's OCF Margin % compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #173 out of 817 companies for OCF Margin %. This places Viemed Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.82. Viemed Healthcare's value of 10.70% is 83.8% above this benchmark. Historically, Viemed Healthcare's own OCF Margin % has ranged from 17.43 to 34.70 over the past decade. While the company's 10-year median is 22.12 vs. the industry median of 5.82, Viemed Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current OCF Margin % of 10.70% is 83.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current OCF Margin % is 10.70%, which is 52% below median its own 10-year median of 22.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.94, compared to a current price of $12.15 — trading 11.1% above its estimated fair value. The current OCF Margin % is 10.70%, which is 52% below median its 10-year median of 22.12 and 83.8% above the Medical Devices & Instruments industry median of 5.82. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current OCF Margin % is 10.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $12.15 is trading 11.1% above its estimated GF Value™ of $10.94.
GuruFocus considers Viemed Healthcare to be Modestly Overvalued.
Key valuation signals for VMD:
OCF Margin %: 10.70% (52% below median its 10-year median of 22.12)
GF Value™: $10.94 vs. price of $12.15 (11.1% above fair value)
Industry Position: 83.8% above the Medical Devices & Instruments median (#173 of 817)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for VMD
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
